Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partial Lateral Internal Sphincterotomy vs Botulinum Toxin A plus Topical Diltiazem for Chronic Anal Fissure
IRCT2013042812294N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A and diltiazem in chronic anal fissure (CAF) (2 arms), sponsored by Tehran University of Medical Sciences. Started Mar 2010; status: completed.
02
Drugs
botulinum toxin type Adiltiazem
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on IRCT2013042812294N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013042812294N3.